The exon junction complex (EJC) plays a major role in posttranscriptional regulation of mRNA in metazoa. The EJC is deposited onto mRNA during splicing and is transported to the cytoplasm where it influences translation, surveillance, and localization of the spliced mRNA. The complex is formed by the association of four proteins (eIF4AIII, Barentsz [Btz], Mago, and Y14), mRNA, and ATP. The 2.2 Å resolution structure of the EJC reveals how it stably locks onto mRNA. The DEAD-box protein eIF4AIII encloses an ATP molecule and provides the binding sites for six ribonucleotides. Btz wraps around eIF4AIII and stacks against the 5 0 nucleotide. An intertwined network of interactions anchors Mago-Y14 and Btz at the interface between the two domains of eIF4AIII, effectively stabilizing the ATP bound state. Comparison with the structure of the eIF4AIII-Btz subcomplex that we have also determined reveals that large conformational changes are required upon EJC assembly and disassembly.
INTRODUCTION
The expression of protein-encoding genes in eukaryotes involves a series of steps, starting from transcription, through processing of the precursor mRNA (pre-mRNA), to translation, and ultimately to decay in the cytoplasm. Although these steps are mechanistically distinct, they are functionally coupled, contributing to the efficiency and fidelity of gene expression (reviewed in Moore, 2005) . A well-known example in this context is the influence of nuclear splicing on translational yield, stability, and localization of mRNAs, events that occur long after the intron lariat has been excised (reviewed in Le Hir et al., 2003) . How the molecular memory of introns is carried forward to the cytoplasm had been a puzzling question until the discovery that splicing not only alters the nucleotide sequence of the nascent transcript but also deposits a protein complex, the exon junction complex (EJC), as a landmark on the transcript (Le Hir et al., 2000) .
In human cells, the EJC is assembled during the second step of splicing, when the lariat has been formed and the exons are being ligated (Reichert et al., 2002) (Shibuya et al., 2004) . The complex is loaded onto the mRNA in a sequence-independent manner at a fixed distance (20-24 nucleotides) upstream of the exon-exon junction (Le Hir et al., 2000) . The EJC remains stably bound at this position as the mature messenger ribonucleoprotein particle (mRNP) is exported to the cytoplasm. The stable core of the complex contains four proteins: Mago, Y14, eIF4AIII, and Barentsz (Btz, also known as MLN51). As it proceeds through the different cellular environments, the EJC core acquires and loses additional factors. Peripherally associated proteins include splicing coactivators (Srm160, Pinin, RNPS1), mRNA export factors (REF/Aly, TAP-p15) and factors involved in cytoplasmic mRNA surveillance (UPF3 and UPF2) (reviewed in Tange et al., 2004) . Thus, the EJC provides a platform for anchoring proteins that function at different steps of mRNA metabolism. The complex is believed to be eventually removed by ribosomes in the first or ''pioneering'' round of translation (Dostie and Dreyfuss, 2002; Lejeune et al., 2002) .
Surveillance of mRNAs by the nonsense-mediated mRNA decay (NMD) pathway has long been known to depend on exon-exon boundaries in human cells (Cheng et al., 1994) . NMD elicits rapid degradation of aberrant mRNAs containing a premature stop codon (PTC) if an exon-exon junction is present at least 50 nucleotides downstream of a stop codon (reviewed in Conti and Izaurralde, 2005; Lejeune and Maquat, 2005) . NMD can be recapitulated by tethering either Mago, Y14, eIF4AIII, or Btz within the 3 0 UTR of a reporter mRNA in human cells, as in the case of the bona fide NMD factor UPF3 (Ferraiuolo et al., 2004; Fribourg et al., 2003; Gehring et al., 2003; Lykke-Andersen et al., 2000; Palacios et al., 2004; Shibuya et al., 2004) . This indicates that when present downstream of a translation termination site, the EJC coordinates a series of interactions necessary for NMD, thus providing the direct molecular link for splicing-dependent PTC recognition. When present upstream of the stop codon (i.e., in a normal situation), the EJC increases the translational yield of the mRNA. Tethering EJC core components within the open reading frame of a reporter mRNA enhances polysome association . The EJC is thus the direct link for the stimulatory effect of splicing on mRNA translation Nott et al., 2003; Wiegand et al., 2003) .
The core components of the human EJC are conserved in other eukaryotes, with the notable exception of S. cerevisiae. Drosophila Mago, Y14, eIF4AIII, and Btz are all essential for the localization of oskar mRNA at the posterior pole of the oocyte (Hachet and Ephrussi, 2001; Mohr et al., 2001; Palacios et al., 2004; van Eeden et al., 1991) . Oskar mRNA localization is required for germ line and abdomen formation in Drosophila and is dependent on splicing (Hachet and Ephrussi, 2004) . In contrast to what is observed in human cells, neither splicing nor the EJC are required for NMD in Drosophila . These data suggest that although a structurally homologous EJC complex exists in Drosophila, the EJC splicing ''mark'' imprinted on the mRNA is interpreted to trigger different cytoplasmic events in this organism. In human cells, Btz has also been found as a component of dendritic mRNPs in hippocampal neurons, suggesting that in humans the EJC might also be involved in either localization or regulated expression of specific mRNAs (Macchi et al., 2003) .
EJC assembly is splicing dependent in vivo but can be recapitulated in vitro when all the constituent components of the complex are simultaneously present (Ballut et al., 2005; Tange et al., 2005) . EJC assembly not only requires the protein components but also depends on the presence of ATP and single-stranded RNA, both of which are an integral part of the complex (Ballut et al., 2005) . The in vitro reconstituted EJC protects eight to nine nucleotides from nuclease digestion, corresponding to the footprint characteristic of the EJC assembled in a splicing reaction (Ballut et al., 2005; Le Hir et al., 2000) .
While Btz displays no homology to proteins of known function, eIF4AIII belongs to the well-studied family of DEAD-box proteins (reviewed in Cordin et al., 2006) . Proteins belonging to this family have RNA-dependent ATPase activity and range from acting as ''molecular motors'' in unwinding nucleic acid duplexes (hence the name ''helicase'') to RNA ''place holders'' as in the case of eIF4AIII (Shibuya et al., 2004; Tanner and Linder, 2001 ). In the EJC, the ATPase activity of eIF4AIII is inhibited by the presence of Mago and Y14 (Ballut et al., 2005) . EJC incorporation is specific for eIF4AIII and does not occur with the highly similar translation initiation factor eIF4AI (Shibuya et al., 2006) .
Understanding how the EJC is formed by the cooperative action of all its constituents requires knowledge of its three-dimensional structure, which we report here at 2.2 Å resolution. The crystal structure of the Mago-Y14-eIF4AIII-Btz-AMPPNP-U 6 RNA complex also explains why the binding of RNA within the EJC is stable and specific, despite being sequence independent. The 3.0 Å resolution structure of the eIF4AIII-Btz subcomplex reveals a dramatic conformational change of the helicase domains as compared to EJC bound eIF4AIII. More generally, we propose that similarly to what observed for protein kinases, members of the DEAD-box family of proteins are likely to adopt a similar structure in their ''on'' state (when bound to ATP and RNA) despite having different conformations in their ''off'' states.
RESULTS

Structure Determination and Quality
The human EJC was reconstituted with the components previously described (Ballut et al., 2005) . Crystals that diffract to 3.2 Å resolution were obtained with the complex of Mago (full length), Y14 (residues 66-174, referred to as Y14DN), eIF4AIII (full length), Btz (the SELOR domain, residues 137-286, Degot et al., 2004) , a nonhydrolyzable ATP analog (AMPPNP), and U 15 RNA. A crystal form that diffracts to 2.2 Å resolution was obtained by reconstituting the EJC with a Y14 construct that also lacks the low-complexity C terminal region (Y14DCDN, residues 66-154) (Figure 1) . The 2.2 Å structure of the EJC (containing Y14DCDN) was determined by molecular replacement and refined to an R free of 21.9% and R factor of 18.8%. It has good stereochemistry, with 91.4% of the residues lying in the most favored regions of the Ramachandran plot (see Table 1 for data collection and refinement statistics). The final model includes six bases of polyU RNA, AMPPNP, essentially all of Mago-Y14 (Mago residues 4-146 and Y14 residues 66-154), most of eIF4AIII (except for the 20 N-terminal residues that are disordered), and two ordered stretches of Btz (residues 168-196 and 215-230) (Figure 1 ). The 3.2 Å structure of the EJC containing Y14DN does not show ordered electron density for the C-terminal region of Y14, but in this crystal form additional residues of Btz can be modeled (residues 168-196 and 214-248 ; R free of 27.7%, R factor of 23.3%).
Overall Architecture of the EJC: A Close-Knit Assembly Centered around eIF4AIII The EJC structure resembles an L-shaped molecule, with eIF4AIII-Btz at the base of the assembly and Mago-Y14 arranged almost perpendicularly to it (Figure 2 ). The core structure of Mago-Y14 in the EJC is essentially identical to that observed for the heterodimer in isolation (Fribourg et al., 2003; Lau et al., 2003; Shi and Xu, 2003) . Mago folds into a flat antiparallel b sheet flanked on one side by two parallel a helices (blue, Figure 2) . The a-helical surface of Mago interacts with the RNA binding domain (RBD) of Y14 (magenta, Figure 2 ). This protein-protein interaction is mediated by the b sheet surface of the RBD that is instead generally used in this type of folds to bind RNA (reviewed in Hall, 2002) . The b sheet surface of Mago is entirely exposed to solvent (Figure 2 ), but part of it is expected to interact with the N-terminal a helix of Y14 (Fribourg et al., 2003) that is not present in the construct crystallized.
The domain organization of eIF4AIII (yellow in Figure 2 ) is typical of the DEAD-box family of proteins, with two RecA-like domains (reviewed in Cordin et al., 2006) . The two domains are arranged to form a deep interdomain cleft where ATP binds (gray, Figure 2 ). Single-stranded RNA (black, Figure 2 ) binds with an overall bent conformation in a shallow cleft across the two RecA-like domains and is flanked on one side by Btz. Btz (red, Figure 2 ) does not have a globular fold; instead it extends with two separate stretches over both domains of eIF4AIII and also contacts Mago. The Mago-Y14 heterodimer interacts mainly with domain 2 of eIF4AIII but also docks into the interdomain cleft. Thus, the components of the EJC engage one another in a network of interactions that are centered at eIF4AIII (summarized in Figure 1 ).
EJC Bound eIF4AIII Has a Closed Conformation
In eIF4AIII, the RecA-like domain 1 (residues 38-240) is joined to domain 2 (residues 251-411) by a 10-residue linker and is flanked by an N-terminal sequence that is characteristic of eIF4AIII ( Figure 1A ). Each RecA-like domain is formed by a parallel b sheet with loops on both the N-terminal and C-terminal ends of the b strands. These loops contain the motifs that are characteristic of the DEAD-box family of proteins (Cordin et al., 2006; Gorbalenya and Koonin, 1993) and are involved in either ATP binding or RNA binding (shown in green for domain 1 and in orange for domain 2 in Figures 3A and 3B) .
Within the EJC, the two domains of eIF4AIII are in close proximity and are oriented in such a way that the b sheets lie almost perpendicular to each other. The overall conformation of eIF4AIII in the EJC structure is similar to that observed for the Vasa helicase in complex with ATP and RNA ( Figure 3C ) (Sengoku et al., 2006) . The two proteins superpose with a root mean square deviation (rmsd) of 1.7 Å over 369 a-carbon atoms, distributed over the entire molecule. This similarity is striking considering that previous structural studies of DEAD-box proteins in the absence of RNA have shown a variety of conformations. However, the comparison between eIF4AIII and Vasa is the first for two different DEAD-box proteins locked in the same on state, i.e., in a productive complex with ATP and nucleic acid.
ATP Is Buried within eIF4AIII and Is Approached by Mago
The ATP binding site is at an interface between the two RecA-like domains of eIF4AIII and is formed by the loops at the C-terminal ends of the domain 1 b strands (motifs Q, I, II, and III) and loops at the N-terminal ends of the domain 2 b strands (motifs V and VI) ( Figure 3A ). Motif I is the socalled Walker A motif (or P loop) and binds the ATP phosphate groups, in particular with Lys88 bridging the b and g phosphates. Motif II is the Walker B motif (the Asp-GluAla-Asp sequence from which the name of the DEADbox family derives). Asp187 of motif II coordinates the magnesium ion together with Thr89 from motif I ( Figure 3E and Figure S1 ). From domain 2, Asp342 of motif V contacts the ribose (at the 3 0 OH), and Arg367 and Arg370 of motif VI interact with the g phosphate of ATP. Of the three water molecules at the active site, one is the likely candidate for being activated by a general base for the in-line nucleophilic attack in the ATPase reaction ( Figure 3E ). This water is at 3.7 Å from the ATP g-phosphate and is coordinated by Glu188 (motif II) and His363 (motif VI), which in turn is hydrogen bonded to Thr220 (motif III).
The adenine base of ATP is bound both with specific hydrogen bonds (with Gln65 in the Q motif) and by stacking interactions (with Phe58 in the Q motif and with Tyr371 in motif VI). The C-terminal residue of Mago (Ile146) makes van der Waals contacts with Tyr371 of eIF4AIII, capping the adenine binding site ( Figure 3E ). Comparison with the structure of Vasa shows that ATP is held in place by a similar set of interactions. The only interaction with ATP that is not present in Vasa is the contribution of the C terminus of Mago to the hydrophobic environment of the adenine base. Instead, in Vasa a hydrophobic residue from the N-terminal flanking region (Phe225) is positioned at a similar structural position to Ile146 of Mago.
Six Ribonucleotides Are Cradled by eIF4AIII and Btz
Single-stranded RNA binds eIF4AIII on the opposite surface from the ATP binding site (Figure 2 ). Although the complex that was crystallized contained a U 15 RNA, ordered electron density is observed only for six nucleotides ( Figure S2 ). The nucleotides bind with the 3 0 end interacting with domain 1 of eIF4AIII and with the 5 0 end interacting with domain 2, where it is stacked against Btz ( Figure 3B ). Contacts are made primarily by the ribose-phosphate backbone of the nucleic acid, with the bases facing the solvent.
The ribose and phosphate moieties bind in consecutive binding pockets formed by the sequential arrangement of the loops at the C-terminal end of the b sheets, which contain conserved helicase motifs ( Figure 3B ). Proceeding from U2 to U6, five phosphates contact sequentially motifs IV, V, QxxR (from domain 2), and Ia, GG, Ib (from domain 1). The fourth nucleotide (U4) is at the interface of the two domains, with its phosphate moiety interacting both with Arg316 and Arg116 (motifs QxxR and Ia, respectively) ( Figures 3D and 3F) . Four of the six nucleotides form hydrogen bonds between the 2 0 -OH groups of the riboses and eIF4AIII: U1 with Asn285 (motif IV), U3 with Pro114 (motif Ia), U4 with Gln200, and U5 with Asp169 (motif Ib) ( Figure 3D ).
The uracyl bases form only a few specific contacts with eIF4AIII ( Figure 3D ). At the 5 0 end, U1 stacks against the aromatic ring of Phe188 of Btz ( Figure 3F ). The bases of U1, U2, U3, and U4 also stack on each other. Between U4 and U5, the RNA bends dramatically, probably due to the position of motif Ib, which would sterically interfere with a straight RNA geometry ( Figure 3B ). This bent conformation of the RNA is similar to that observed in the Vasa helicase ( Figure 3C ), where it was suggested to play a role in unwinding of nucleic acids (Sengoku et al., 2006) .
Btz Wraps around eIF4AIII and Mediates eIF4AIII-Specific Contacts
The SELOR domain of Btz is molded on the surface of eIF4AIII with two separate stretches interacting with two distinct sites (Figure 2 ). The N-terminal stretch (residues 168-196) binds to domain 2 of eIF4AIII and the C-terminal stretch (residues 214-248) binds to domain 1. The two stretches contain all the residues of Btz that are conserved across species ( Figure 1B ). They are connected by a flexible linker, as judged by the lack of ordered electron density (represented by a dotted line in Figure 2A ).
The C-terminal stretch of Btz binds to the loops at the N-terminal end of the domain 1 b sheet. In this area there are extensive hydrophobic interactions: Btz Trp218 
Sequence Conservation and Interactions in the EJC
Structure-based sequence alignment. The secondary structure elements are shown below the sequences (h for a helices, b for b strands, and dots for extended/loop regions). Conserved residues are colored according to sequence alignments including orthologs from H. sapiens (Hs), D. melanogaster (Dm), and C.elegans (Ce) (shown), and also from X. laevis (Xl) and D. rerio (Dr) (not shown). (A) In the eIF4AIII alignment, conserved sequence motifs shared by all DEAD-box helicases are boxed in gray and labeled (Cordin et al., 2006; Sengoku et al., 2006) . Highlighted in yellow are residues that are conserved specifically in eIF4AIII orthologs (Hs, Dm, Ce, Xl, Dr) and not in eIF4AI (Hs and Sc included in the alignment, and also Dm, Ce, Xl, Dr and Sc, not included). Above the sequences, fully colored circles identify residues involved in the interaction with ATP (gray circles), with RNA (black circles), with Mago (blue circles), with Y14 (magenta circles), and with Btz (red circles). Residues shown by mutagenesis studies to affect protein-protein interactions or NMD are surrounded by a black square or circle, respectively (Oberer et al., 2005; Shibuya et al., 2006) . (B-D) Btz (MLN51), Mago, and Y14 alignments. Conserved residues are highlighted in red (Btz), blue (Mago) and magenta (Y14). Fully colored circles above the sequences are as in panel (A). Yellow circles identify the interaction sites for eIF4AIII. Other interactions known from previous structural studies are indicated as colored empty circles above the sequences. In panels (C) and (D), empty orange circles identify residues of Mago-Y14 interacting with PYM (Bono et al., 2004) , while empty blue and magenta circles identify residues involved in the interaction between Mago and the Nterminal helix of Y14 (Fribourg et al., 2003) that is missing in the EJC construct crystallized. Residues shown by mutagenesis studies to affect proteinprotein interactions or NMD are surrounded by a black square (panel B [Ballut et al., 2005] or a circle in panels C and D [Fribourg et al., 2003] and His220 are in van der Waals contact with Tyr205 and Phe232 of eIF4AIII, while Btz Phe223 flanks eIF4AIII Pro210 ( Figure 4A ). Hydrophilic contacts are made by Btz Asp221 and Gln228, which are adjacent to eIF4AIII Arg206 and Thr178, respectively. In addition, eIF4AIII Asp154 and Tyr155 are in contact with Btz Tyr240 and Arg245, in a region of Btz that could only be modeled in the 3.2 Å crystal form. Mutation of Btz residues Trp218 and Asp221 impairs the interaction with eIF4AIII and the localization of the Btz SELOR domain at nuclear speckles (corresponding to the W49 and D52 mutations in Ballut et al., 2005) . Many of the helicase residues in this region are conserved within eIF4AIII orthologs but are not present in other highly similar proteins such as eIF4AI (see yellow shading in Figure 1A ), suggesting that this interaction site is important to confer specificity to eIF4AIII recognition.
A Network of Interactions between Btz, Mago, Y14, and eIF4AIII
The N-terminal stretch of Btz binds domain 2 of eIF4AIII with the main chain winding in between RNA and Mago ( Figure 4B ). Several interactions within Btz appear important to maintain such a conformation (in particular at Arg184 and Phe188, Figure 4B ). A subset of conserved residues of Btz contact eIF4AIII: Btz Pro179 makes van der Waals contacts with eIF4AIII Trp292, and Btz Arg184 and Arg194 form salt bridges with eIF4AIII Asp385 and Asp391, respectively. A cluster of electrostatic interactions is formed between Btz Glu190, Mago Lys41, eIF4AIII Glu224, and Glu359 ( Figure 4B ). The side chains of Mago, Lys41, Tyr40, Phe17, and Lys16 participate in stacking interactions that also involve the aliphatic portion of eIF4AIII, which in turn forms a salt bridge with Mago Glu20 ( Figure 4B ). Overall, this complex network of interactions results in the insertion of Btz and of the two long loops of Mago (spanning residues 14-19 and 37-45) into the interface between the two domains of eIF4AIII. The importance of these contacts is underscored by the effect of mutations in the 16-17 loop of Mago that impair both NMD in human cells and oskar mRNA localization in Drosophila embryos (Fribourg et al., 2003; Newmark and Boswell, 1994 ). Another cluster of interactions is centered at the C-terminal helix of eIF4AIII (residues 384-396) ( Figure 4C ). On one side, Arg390 and Asp401 of eIF4AIII form a salt bridge and together with Glu402 interact with Mago Tyr123 and Gln127 and with Y14 Arg108. On the other side, the C-terminal helix interacts via Asp391 with Mago Lys103 and Btz Arg194 and contacts Asp43 of Mago via Tyr395. Thus, the C-terminal helix of eIF4AIII is at the intersection with the other three proteins of the complex.
Mago-Y14 Shields the Linker between the eIF4AIII Domains
Adjacent to the C-terminal helix of eIF4AIII, we find the linker that connects the two RecA-like domains wedged in between the b sheet and the long a helix of Mago (Figure 4D) . Overall, the linker region between the two RecAlike domains is anchored with extensive interactions. 
DEAD-box helicase eIF4AIII (in yellow). Both proteins interact with RNA (in black)
, which is bound at a cleft formed between the two RecA-like domains of eIF4AIII. ATP (in gray) binds at an interface between the two domains of eIF4AIII, distinct from the RNA binding cleft. The other two protein components of the EJC, Mago (blue), and Y14 (magenta), bind mainly to domain 2 of eIF4AIII, but the interaction surface also extends over to the interface with domain 1. The dotted line in red shows the approximate path of a portion of Btz not present in the electron density (residues 198-213; Figure 1) . The helix at the C-terminal stretch of Btz is present in the 3.2 Å resolution structure (shown), while it is partially disordered in the 2.2 Å structure. The two EJC structures are otherwise virtually identical. All ribbon drawings were rendered using PyMOL (DeLano, W.L., 2002, http://www.pymol.org).
The linker has a pronounced kink at residues 242-250. Within the kinked region, Asp244 and Glu245 form a direct salt bridge with Lys48 from the b sheet of Mago, and Arg243 interacts with Asp43 from one of the two long loops of Mago (the 37-45 loop, which in turns contacts Btz, discussed above).
Proceeding from the kink toward domain 1, the linker Lys242 engages in a salt bridge with Glu29, within the N-terminal flanking region of eIF4AIII. From the kink toward domain 2, the linker is involved in interactions with both Mago and Y14 ( Figure 4D ): eIF4AIII Glu249 is flanked by Mago Lys144 and contacts Asn101 and His103 of Y14. This cluster of interactions holds the C-terminal end of Mago so as to position Mago Ile146 at the ATP binding site. Interestingly, in the case of Vasa, the linker follows a similar path and is flanked by an insertion (residues 224-232) that occupies a similar structural position as the C-terminal region of Mago.
Large Conformational Change between EJC Bound and Unbound eIF4AIII
The two domains of eIF4AIII in the EJC are highly interconnected with ATP, RNA, and Mago-Y14. This prompted us to ask whether the same interdomain orientation is present in the absence of these factors. To determine the structure of the eIF4AIII-Btz subcomplex, we used an eI-F4AIII construct (residues 38-411) lacking the N-terminal sequence that flanks the helicase domains and a Btz construct trimmed to residues 137-250. The structure is refined at 3.0 Å resolution to an R free of 32.5% and R factor of 27.1%. The relatively high R free is likely due to a combination of weak diffraction data (Table 1) and of the significant proportion of poorly ordered residues of Btz. Nevertheless, the electron density map shows a good agreement with the model, which includes residues 38-408 of eIF4AIII and 217-225 of Btz ( Figure S2 ).
The structure of the eIF4AIII-Btz reveals a striking difference in the conformation of the helicase as compared to the conformation observed in the EJC. Superposition of the two structures at domain 1 of eIF4AIII shows that domain 2 occupies diametrically opposite positions (Figure 5A ). In the eIF4AIII-Btz subcomplex, motifs Q, I, II, and III of domain 1 face the solvent rather than facing domain 2 ( Figure 5B ). Thus in the off state, the ATP binding site is completely open and the RNA binding site is disrupted. The pivot point for the swiveling motion between the two domains appears to reside in the linker region, which bends away with a roughly 180
angle from the path observed in the EJC ( Figure 5B ). The diversion occurs at residue 242 of eIF4AIII. In particular, Asp244 and Leu246 in the linker interact with motif VI, whereas in the EJC structure Asp244 points toward Mago ( Figure 4D ) and Leu246 points toward motif I instead ( Figure 5B) .
The contacts between the two domains of eIF4AIII are fewer in this ''open'' structure than they are in the ''closed'' EJC conformation. Contacts between domain 1 and 2 in the eIF4AIII-Btz subcomplex include Gln81 (at the edge of motif I) with Arg370 (in motif VI) and Arg238 with Gln345 (at the edge of motif V). In contrast, within the EJC, Arg238 packs against Phe28 from the N-terminal flanking sequence of eIF4AIII ( Figure 5B ). Interestingly, in both conformations the residues of eIF4AIII corresponding to the main interaction site of eIF4AI with the middle domain of eIF4G (Asp270, Asp273, Asn301, and Thr303; Figure 1A and Oberer et al., 2005) are exposed to solvent and accessible. It is known that eIF4AIII can also bind eIF4G (Li et al., 1999) , but whether the conformation it acquires upon eIF4G binding is compatible with the closed EJC bound conformation and whether binding can also occur in the context of the EJC is currently unknown.
DISCUSSION
ATPase Inhibition in the EJC
The EJC has been proposed to function as a place holder on mRNA (Shibuya et al., 2004) , onto which it is locked by inhibition of eIF4AIII ATPase activity (Ballut et al., 2005) . One possible mechanism for the inhibition is that in the context of the EJC the ATPase site of eIF4AIII is disrupted. However, comparison with the structure of another DEADbox protein (Vasa) bound to ATP and RNA shows that in the EJC eIF4AIII has a similar mode of ATP and RNA binding. All the residues at the ATP site appear to be in the proper conformation for catalysis, including a water molecule that is at the appropriate distance and with the correct geometry to carry out the nucleophilic attack required for the ATPase reaction. Thus, the mechanism by which the ATPase activity is inhibited in the EJC does not reside in disruption of the active site. Rather, the ATPase inhibition appears to be due to locking the RNA bound conformation of eIF4AIII. This is achieved by positioning Mago-Y14 and Btz at the ''closed'' crevice that forms between the two domains of eIF4AIII when ATP and RNA are bound. Such positioning is mediated by an extensive and intertwined set of interactions between all components of the complex.
This mechanism of ATPase inhibition is consistent with the results of previous studies. Mutations that impair the Walker A and B motifs of eIF4AIII have no effect on either EJC formation or NMD (Shibuya et al., 2006) , in line with the observation that the ATPase active site is not involved. Mutations that have been shown to affect NMD map at residues that participate in crucial protein-protein interactions in the EJC structure. These include residues at the interface between Mago and Y14 (at Y14 Leu118 and Mago Leu136; Fribourg et al., 2003) and residues at the interface between Mago, eIF4AIII, and Btz (Mago Lys16 and Phe 17, Fribourg et al., 2003;  and at the C-terminal helix of eIF4AIII, Shibuya et al., [2006] ). All constituents of the complex are required to lock the RNA in the EJC. Indeed, mutations in eIF4AIII that interfere with either protein interactions (at the C-terminal region of eIF4AIII), with the binding of the g-phosphate of ATP (at motif VI) or with RNA (at motif Ib), have similar consequences in impairing EJC formation in vitro and NMD in vivo (Shibuya et al., 2006) . 
Mode of RNA Binding
The mode of RNA binding we observe in the EJC structure explains several biochemical observations. First, eIF4AIII and Btz are the only components that contact RNA directly in the complex, as predicted from UVcrosslinking experiments (Ballut et al., 2005; Shibuya et al., 2004) . It also explains why the complex is resistant to RNase A (Ballut et al., 2005) , as the RNA is cradled in such a way that the backbone is inaccessible from the solvent. While we observe direct interactions with six nucleotides, biochemically eight to nine nucleotides are protected in the EJC from nuclease digestion (Ballut et al., 2005; Le Hir et al., 2000) . It is possible that the remaining two to three nucleotides do not bind tightly to the complex but are nevertheless sterically inaccessible to RNases. The extensive contacts we observe with the 2 0 -OH groups of the ribose moieties reflect the specificity for RNA in the assembly of the EJC, which does not form with DNA (data not shown). The paucity of specific interactions with the bases provides a structural rationale for how the EJC can form in a sequence-independent manner. When reconstituted with recombinant proteins, the EJC does not form at a specific position on the RNA. Why the EJC is deposited in a position-dependent manner upon splicing will likely depend on the geometric constraints of the splicing machinery that is required to assemble the complex in vivo. The RNA conformation has a pronounced bend, similar to that observed in the structure of Vasa, an unwinding DEAD-box helicase (Sengoku et al., 2006) . Given that the EJC functions as a place holder on RNA rather than as an unwinding motor, the RNA bending we observe in the complex is unlikely to function in strand separation. It is possible that RNA bending has a role in unwinding nucleic acids when eIF4AIII is in isolation or that it has a different role in the EJC (for example, in positioning proteins bound upstream and downstream on the mRNA with a particular geometry that might be important for interactions). It is also possible that RNA bending is simply the outcome of the geometry of secondary structure elements in DEAD-box helicases and has no direct function. In general, the similarity between eIF4AIII and Vasa in the on state (bound to ATP and RNA) suggests that other DEAD-box proteins will adopt a similar conformation to satisfy the chemical constraints of the active state. In contrast, DEAD-box proteins are not subject to such constraints in the off state and therefore do not necessarily adopt a particular conformation. This situation is highly reminiscent to what observed for protein kinases (reviewed in Huse and Kuriyan, 2002) .
Implications for EJC Assembly and Disassembly
At the biochemical and structural level, the EJC can be dissected into two subcomplexes: Mago-Y14 and eIF4AIII-Btz. Biochemically, they form stable heterodimers (see Experimental Procedures and also Fribourg et al., 2003; Shibuya et al., 2006) . Structurally, the interactions within each heterodimer are mediated by significant hydrophobic contacts. In contrast, the interactions between Mago-Y14 and eIF4AIII-Btz in the EJC are mainly hydrophilic and are cushioned by a layer of water molecules. This is consistent with the notion that unzipping of macromolecular complexes occurs through interfaces held together by hydrogen bonds, suggesting that the two subcomplexes might be an intermediate step in EJC assembly/disassembly ( Figure S3 ). In this model, eIF4AIII-Btz has to undergo a large conformational change upon EJC incorporation, while Mago-Y14 behaves as a rather rigid unit. The transition between the open off state of eIF4AIII (in the eIF4AIII-Btz subcomplex) and the closed on state (in the EJC) is likely mediated by the flexible linker of the two RecA-like domains and coordinated by the binding of all constituents of the complex.
A similar conformational change would also occur upon EJC disassembly. A possible scenario for EJC disassembly is the dissociation of Mago-Y14 by the interaction of translating ribosomes and/or additional factors. The cytosolic protein PYM is known to be connected to EJC components and involved in NMD, as shown by the effect of mutating the interface between PYM and Mago (Bono et al., 2004) . The binding mode of PYM to Mago-Y14 observed in the structure of the PYM-Mago-Y14 ternary complex (Bono et al., 2004) would not be compatible in the EJC, as PYM Tyr33 would clash with Pro404 and Met405 of eIF4AIII ( Figure S4 ). This steric clashing would be even more dramatic in the context of full-length PYM, raising the interesting possibility that the function of PYM in NMD might reside in a disassembly step of the EJC in the cytosol. Upon dissociation of Mago-Y14, hydrolysis of ATP would occur promptly since the ATPase active site of eIF4AIII is already correctly positioned for catalysis. Release of the g-phosphate of ATP would in turn destabilize the RNA bound conformation.
This model does not exclude that another intermediate step has to occur, namely the association/dissociation between eIF4AIII and Btz. While Mago-Y14 is likely a constitutive heterodimer, the structure of eIF4AIII-Btz has a rather small interaction site, suggesting that this subcomplex might be more labile. This is consistent with localization data: at steady state, Mago, Y14, and eIF4AIII localize in the nucleoplasm and in nuclear speckles Kim et al., 2001; Le Hir et al., 2001; Palacios et al., 2004) . In contrast, Btz is localized mainly in the cytoplasm, while the nuclear speckles localization of its SELOR domain depends on the interaction with eIF4AIII (Ballut et al., 2005; Shibuya et al., 2004; Palacios et al., 2004) .
Btz appears to function with an ''anchoring'' site and an ''effector'' site. The anchoring site (the C-terminal stretch) is essential and sufficient to bind to domain 1 of eIF4AIII, even in the absence of other EJC components. The effector site (the N-terminal stretch) interlocks the complex when the other EJC components are present by binding simultaneously to eIF4AIII, RNA, and Mago-Y14. The anchoring is achieved on a surface of eIF4AIII that is conserved across different species but is not conserved in paralogs, including eIF4AI. This is likely to provide the means of discriminating eIF4AIII from closely related DEAD-box proteins, many of which are present in the splicing machinery and are not incorporated into the EJC. On the other hand, eIF4AIII does not enhance translation initiation, in contrast to eIF4AI (Li et al., 1999) . Structural studies will ultimately be required to understand what is key to the precision of the translation initiation machinery in discriminating against eIF4AIII. Finally, the mechanism by which the EJC orchestrates the downstream networks of interactions leading to NMD, mRNA localization, and enhanced incorporation into polysomes are open questions for future studies.
EXPERIMENTAL PROCEDURES
Protein Preparation
Full-length (fl) human eIF4AIII (residues 1-412; untagged) and the SELOR domain of Btz (residues 137-286; TEV-cleavable GST tagged) were cloned into a bicistronic vector (pETMCN-GST, gift from C. Romier, IGBMC, Strasbourg) and coexpressed in E. coli. Cells were lysed in 20 mM Tris-HCl pH 7.5, 300 mM NaCl, 1 mM DTT, 10% glycerol. The complex was purified by Glutathione Sepharose 4B (GE Healthcare), cleaved with TEV protease, and further purified on a Heparin Sepharose CL-4B column (GE Healthcare). The complex between eIF4AIII 38-412 and Btz 137-250 was prepared using a similar protocol.
The complexes of fl human Mago (residues 1-147) with Y14DN (residues 66-174) or with Y14DNDC (66-154) were prepared by coexpression from a bicistronic vector (pETMC-His, gift from C. Romier, IGBMC, Strasbourg) and purified with a similar protocol as previously described for the Drosophila orthologs (Fribourg et al., 2003) . For EJC complex formation, eIF4AIII(fl)-Btz(137-286) was incubated with 2 mM AMP-PNP, 2 mM MgCl 2 , and a 1.53 molar excess of a U 15 RNA (or an A 20 RNA) (Dharmacon) to which was added Mago-Y14DN (or Mago-Y14DNDC). The mixture was purified using size-exclusion chromatography (Superdex 200) in the presence of 3 mM MgCl 2 . Although the EJC is stable in the presence of ATP (Ballut et al., 2005) , the nonhydrolysable AMP-PNP analog was used to ensure sample homogeneity during crystallization.
Crystallization and Data Collection
Initial crystals of eIF4AIII(fl)-Btz(137-286)-Mago-Y14DNDC-U 15 -AMPPNP grew at 18 C in 8% PEG 6000, 100 mM MgCl 2 , and 100 mM MES pH 6.0, a condition of the ''Complex screen'' (Radaev et al., 2006) . Smaller crystals were also obtained with the EJC reconstituted with the A 20 RNA. The U 15 RNA-containing crystals were optimized by microseeding and grew to a size of 80 3 80 3 200 mm. They diffract to 2.2 Å resolution and contain one EJC per asymmetric unit. Crystals of eIF4AIII(fl)-Btz(137-286)-Mago-Y14DN-U 15 -AMPPNP were obtained at 18 C in 10% PEG 4000, 200 mM ammonium-acetate, 10 mM CaCl 2 , and 50 mM Na cacodylate pH 6.5. The crystals grew as needles to a maximum size of 20 3 20 3 150 mm. They diffract to 3.2 Å resolution and contain two EJCs per asymmetric unit. Crystals of eIF4AIII(38-412)-Btz(137-250) grew at 18 C in 700 mM diammonium tartrate, 100 mM Na acetate pH 4.6 as needles of 15 3 15 3 150 mm dimensions. They diffract to 3 Å resolution and contain two molecules per asymmetric unit. All crystallographic data were measured at the PX beamline X06SA at the Swiss Light Source (SLS), Switzerland, using the microdiffractometer in the case of the needle-like crystal form. For data collection, all crystals were stabilized in a solution consisting of the mother liquor supplemented with 30% glycerol and flash cooled in a nitrogen stream at 100K. Data were indexed and scaled using XDS (Kabsch, 1993) .
Crystal Structure Determination Molecular replacement was carried out with PHASER (McCoy et al., 2004) and refinement with REFMAC (Murshudov et al., 1997) . The search models for the EJC included the Mago-Y14 structure (PDB entry 1P27) and the two separate domains of eIF4A, with which human eIF4AIII shares 62% sequence identity (PDB entries 1FUU and 1FUK). The Arp/Warp program for automated model building (Perrakis et al., 1999) was used to trace the initial model in the 2.2 Å resolution EJC structure. The model was completed using iterative cycles of model building in Coot (Emsley and Cowtan, 2004 ) and restrained refinement. The refinement was carried out by defining each domain/protein as a TLS group in the modeling of anisotropy within REFMAC.
The refined 2.2 Å resolution model of EJC containing Y14DNDC was used as search model for the 3.2 Å crystal form (with Y14DN). Refinement in REFMAC was carried out with tight noncrystallographic symmetry restraints between the two copies of the EJC in the asymmetric unit. For the binary complex, the two domains of eIF4AIII were used as models for the molecular replacement. Refinement was carried out with tight noncrystallographic symmetry restraints between the two molecules, with each eIF4AIII domain defined as a TLS group in the modeling of anisotropy in REFMAC.
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